Literature DB >> 3857945

The proliferation in suspension of the progenitors of the blast cells in acute myeloblastic leukemia.

N Nara, E A McCulloch.   

Abstract

A minority of blast cells in acute myeloblastic leukemia (AML) form colonies in culture in methylcellulose when stimulated by media conditioned by normal leukocytes in the presence of phytohemagglutinin (PHA-LCM). Blast colonies can be replated successfully, either as pooled cells or suspensions from single colonies. However, the plating efficiency declines with repeated passages, and more than four subcultures have not been achieved. In this study, blast populations were cultured in suspension, with fetal calf serum, alpha-minimal essential medium and PHA-LCM. In cells from 17 of 18 patients, exponential growth of clonogenic blast cells was maintained for six to seven days without reculturing. Colonies obtained from progenitors taken from liquid culture and replated in methylcellulose were replated to obtain the secondary plating efficiency (PE2). In 14 cases, this value was maintained or increased. In three instances, PE2 fell following culture in methylcellulose. When cells in suspension were recultured, exponential growth continued. In nine instances, exponential growth was maintained for from seven to 70 days. During this time, PE2 was maintained. Results from experiments using velocity sedimentation separation and analysis of single colonies were consistent with the view that the increase in clonogenic cells in suspension was a manifestation of their self-renewal capacity. The observations also support a model of blast progenitor growth that contains the postulate that these are capable not only of self-renewal but also of determination-like events leading to loss of proliferative capacity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3857945

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.

Authors:  A Pinto; D Aldinucci; V Gattei; V Zagonel; G Tortora; A Budillon; Y S Cho-Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

2.  Introduction of new genetic material into human myeloid leukemic blast stem cells by retroviral infection.

Authors:  L J Smith; S Benchimol
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

3.  In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity.

Authors:  N Van der Lely; T De Witte; J Wessels; R Raymakers; P Muus; F Preijers
Journal:  Ann Hematol       Date:  1994-05       Impact factor: 3.673

4.  In vitro effect of r-verapamil on acute myelogenous leukemia blast cells: studies of cytokine secretion and cytokine-dependent blast proliferation.

Authors:  O Bruserud; I Nesthus; G Pawelec
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

5.  T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia.

Authors:  G Y Cheng; M D Minden; B Toyonaga; T W Mak; E A McCulloch
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

6.  A new approach to the evolution of the blastic crisis from chronic myelocytic leukemia: dynamic interplay of cellular alterations and a changing microenvironment.

Authors:  Z Grossman
Journal:  EMBO J       Date:  1986-04       Impact factor: 11.598

7.  In vitro sensitivity of clonogenic cells in resisting and relapsing patients with acute myelogenous leukaemia.

Authors:  J P Marie; R Zittoun; D Thevenin
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

8.  Membranes replace irradiated blast cells as growth requirement for leukemic blast progenitors in suspension culture.

Authors:  N Nara; E A McCulloch
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

9.  Interleukin 1 enhances growth factor-dependent proliferation of the clonogenic cells in acute myeloblastic leukemia and of normal human primitive hemopoietic precursors.

Authors:  T Hoang; A Haman; O Goncalves; F Letendre; M Mathieu; G G Wong; S C Clark
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

10.  Effects of recombinant human granulocyte colony-stimulating factor (G-CSF) on blast progenitors from acute myeloblastic leukaemia patients.

Authors:  N Nara; I Murohashi; T Suzuki; Y Yamashita; Y Maruyama; N Aoki; S Tanikawa; Y Onozawa
Journal:  Br J Cancer       Date:  1987-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.